Back
iShares ESG MSCI EM Leaders ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
54
LDEM
iShares ESG MSCI EM Leaders ETF
Last Price:
$57.37
Seasonality Move:
-1.47%
Sell
29
ZBIO
Zenas BioPharma, Inc.
Last Price:
$34.77
Seasonality Move:
0.59%
Buy
54
iShares ESG MSCI EM Leaders ETF (LDEM)
is a Buy
Is iShares ESG MSCI EM Leaders ETF a Buy, Sell or Hold?
-
The current iShares ESG MSCI EM Leaders ETF [LDEM] share price is $56.71. The Score for LDEM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
LDEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LDEM Stock Price Chart
What is iShares ESG MSCI EM Leaders ETF's stock price today?
-
The iShares ESG MSCI EM Leaders ETF share price today is $56.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDEM is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $35.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.
LDEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 29.76 | Sell |
| Chaikin Money Flow: | -1286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.93 - 59.31) | Sell |
| Bollinger Bands (100): | (56.3 - 59.74) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 49.55 | Sell |
| Chaikin Money Flow: | -89322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.22 - 39.36) | Sell |
| Bollinger Bands (100): | (17.16 - 33.88) | Buy |
LDEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.38 | Sell |
| 20-day SMA: | 58.49 | Sell |
| 50-day SMA: | 59.09 | Sell |
| 200-day SMA: | 54.43 | Buy |
| 8-day EMA: | 58.07 | Sell |
| 20-day EMA: | 58.52 | Sell |
| 50-day EMA: | 57.6 | Sell |
| 200-day EMA: | 36.67 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.84 | Sell |
| 20-day SMA: | 37.69 | Sell |
| 50-day SMA: | 32.84 | Buy |
| 200-day SMA: | 17.75 | Buy |
| 8-day EMA: | 7.96 | Buy |
| 20-day EMA: | 3.41 | Buy |
| 50-day EMA: | 1.4 | Buy |
| 200-day EMA: | 0.36 | Buy |
iShares ESG MSCI EM Leaders ETF Earnings Growth & LDEM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
iShares ESG MSCI EM Leaders ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||